FTC sues over allegedly inflated insulin prices
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made ...
Qualcomm wants to buy Intel
At the time, Intel CEO Pat Gelsinger said the company would stop all nonessential work and has since announced it will spin ...
Wall Street Termina Dispar Tras Una Semana De Récords
La bolsa de Nueva York terminó dispar este viernes, en una pausa tras una larga serie de subidas que llevó a los índices principales a nuevos récords tras el recorte de tasas de la Reserva Federal ...
S&P advances more than 1% in historic week after Fed starts rate-cut cycle with a bang
The S&P 500 (SP500) on Friday added 1.36% for the week to end at 5,702.53 points, posting gains in three out of five sessions. Read more here.
Snopes.com48m
Exploding Goats? Fake CNN Video Claimed Israel Targeted Hezbollah with Bizarre New Strategy
For example, the X user Wall Street Silver (@WallStreetSilv) posted (archived), "BREAKING NEWS: Mass Hezbollah Casualties ...
Qualcomm Asked Chip Rival Intel if It Would Consider a Sale
The chipmaker Qualcomm has approached its rival Intel in recent days about the possibility of acquiring the slumping Silicon ...
Qualcomm may be mulling an Intel takeover, report claims — what you need to know
However, the WSJ reports that a deal is "far from certain," according to sources familiar with the matter. Intel may or may ...
FTC Chair Lina Khan welcomes companies weighing antitrust in deals, addresses critics
U.S. Federal Trade Commission Chair Lina Khan on Friday welcomed that companies are weighing antitrust considerations early ...
Report: San Diego's Qualcomm Made Bid to Take Over Chip Pioneer Intel
The Wall Street Journal reported Friday that San Diego-based wireless giant Qualcomm has approached Intel about a possible ...
Reuters on MSN1h
Wall Street mixed, Dow hits another high
U.S. stocks ended mixed on Friday although the Dow Jones Industrial Average rose and notched another record high close. Alex Cohen has more.
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...